Movement Disorders (revue) - Checkpoint (Ncbi)

Index « Mesh.i » - entrée « Nerve Tissue Proteins »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Nerve Tissue < Nerve Tissue Proteins < Nervous System  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 179.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000042 (1999) M. Neystat [États-Unis] ; T. Lynch ; S. Przedborski ; N. Kholodilov ; M. Rzhetskaya ; R E BurkeAlpha-synuclein expression in substantia nigra and cortex in Parkinson's disease.
000153 (1999) J E Ahlskog [États-Unis] ; R J Uitti ; M K O'Connor ; D M Maraganore ; J Y Matsumoto ; K F Stark ; M F Turk ; O L BurnettThe effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease.
000184 (2000) D S Latchman [Royaume-Uni] ; R S CoffinViral vectors in the treatment of Parkinson's disease.
000296 (2000) T. Klockgether [Allemagne] ; U. Wüllner ; A. Spauschus ; B. EvertThe molecular biology of the autosomal-dominant cerebellar ataxias.
000306 (2000) H T Benamer [Royaume-Uni] ; J. Patterson ; D J Wyper ; D M Hadley ; G J Macphee ; D G GrossetCorrelation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake.
000326 (2000) E. Jaros [Royaume-Uni] ; D J BurnThe pathogenesis of multiple system atrophy: past, present, and future.
000375 (2000) M. Farrer [États-Unis] ; T. Destée ; E. Becquet ; F. Wavrant-De Vrièze ; V. Mouroux ; F. Richard ; L. Defebvre ; S. Lincoln ; J. Hardy ; P. Amouyel ; M C Chartier-HarlinLinkage exclusion in French families with probable Parkinson' s disease.
000477 (2001) J M Henderson [Australie] ; W P Gai ; M A Hely ; W G Reid ; G L Walker ; G M HallidayParkinson's disease with late Pick's dementia.
000501 (2001) L I Golbe [États-Unis] ; A M Lazzarini ; J R Spychala ; W G Johnson ; E S Stenroos ; M H Mark ; J I SageThe tau A0 allele in Parkinson's disease.
000607 (2001) S. Bostantjopoulou [Grèce] ; Z. Katsarou ; A. Papadimitriou ; V. Veletza ; G. Hatzigeorgiou ; A. LeesClinical features of parkinsonian patients with the alpha-synuclein (G209A) mutation.
000609 (2001) A. Varrone [États-Unis] ; K L Marek ; D. Jennings ; R B Innis ; J P Seibyl[(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy.
000620 (2001) P. Pastor [Espagne] ; E. Mu Oz ; M. Ezquerra ; V. Obach ; M J Martí ; F. Valldeoriola ; E. Tolosa ; R. OlivaAnalysis of the coding and the 5' flanking regions of the alpha-synuclein gene in patients with Parkinson's disease.
000651 (2002) Walter Pirker [Autriche] ; Schiva Djamshidian ; Susanne Asenbaum ; Willibald Gerschlager ; Gotthard Tribl ; Martha Hoffmann ; Thomas BrückeProgression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study.
000656 (2002) Annie Lannuzel [France] ; Patrick P. Michel ; Dominique Caparros-Lefebvre ; Jacqueline Abaul ; Reynald Hocquemiller ; Merle RubergToxicity of Annonaceae for dopaminergic neurons: potential role in atypical parkinsonism in Guadeloupe.
000722 (2002) Yun J. Kim [Canada] ; Masanori Ichise ; James R. Ballinger ; Douglas Vines ; Sean S. Erami ; Tatsuro Tatschida ; Anthony E. LangCombination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.
000802 (2002) Y. Kim [Corée du Sud] ; J-M Kim ; J-W Kim ; C-I Yoo ; C R Lee ; J H Lee ; H K Kim ; S O Yang ; H K Chung ; D S Lee ; B. JeonDopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: what does it mean?
000822 (2002) Katrina Gwinn-Hardy [États-Unis]Genetics of parkinsonism.
000835 (2002) Johannes Schiefer [Allemagne] ; G Bernhard Landwehrmeyer ; Hans-Gerd Lüesse ; Arne Sprünken ; Christiane Puls ; Anna Milkereit ; Eva Milkereit ; Christoph M. KosinskiRiluzole prolongs survival time and alters nuclear inclusion formation in a transgenic mouse model of Huntington's disease.
000851 (2002) Masataka Nishimura [Japon] ; Ryuji Kaji ; Mitsuhiro Ohta ; Ikuko Mizuta ; Sadako KunoAssociation between dopamine transporter gene polymorphism and susceptibility to Parkinson's disease in Japan.
000859 (2002) Spiridon Papapetropoulos ; Christos Paschalis ; John Ellul ; Thodoros Papapetropoulos ; Aglaia AthanassiadouSurvival duration of Parkinson's disease patients living in Greece who carry the G209A alpha-synuclein mutation.
000945 (2002) John L. Goudreau [États-Unis] ; Demetrius M. Maraganore ; Matthew J. Farrer ; Timothy G. Lesnick ; Andrew B. Singleton ; James H. Bower ; John A. Hardy ; Walter A. RoccaCase-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Nerve Tissue Proteins" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Nerve Tissue Proteins" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Nerve Tissue Proteins
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024